RecruitingPhase 1 / Phase 2NCT07725380
135
studies recruiting now
as of 7 Sept 2026
749
studies registered in total
as of 7 Sept 2026
23
countries with a recruiting site
as of 7 Sept 2026
24 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1 / Phase 2NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecruitingNCT00411060
Clinical Orthopaedic Data Bank (Acute and Chronic)
RecruitingPhase 1 / Phase 2NCT06465199
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1 / Phase 2NCT06541262
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 135 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Osteosarcoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Osteosarcoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (CHEK2, RB1, TP53).
Treatments being studied
3 approved treatments and 55 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Levoleucovorin Calcium (Fusilev)Approved: Leucovorin Calcium (Leucovorin calcium)Approved: Levoleucovorin (Khapzory)
Phase 3Gemcitabine (Gemzar)
Phase 3Ifosfamide (Ifex)
Phase 3Etoposide (Etoposide)
Phase 3Doxorubicin (Adriblastina)
Phase 3Methotrexate (Ebetrex)
Phase 3Socazolimab
Phase 3Docetaxel (Beizray)
Phase 2/3Rivoceranib
+ 47 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).